Kazia Therapeutics (KZIA) Short Interest Ratio & Short Volume $3.30 -0.24 (-6.77%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$3.26 -0.04 (-1.21%) As of 04/17/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kazia Therapeutics Short Interest DataKazia Therapeutics (KZIA) has a short interest of 81,200 shares, representing 1.63% of the float (the number of shares available for trading by the public). This marks a -29.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 171,459 shares to cover all short positions.Current Short Interest81,200 sharesPrevious Short Interest115,900 sharesChange Vs. Previous Month-29.94%Dollar Volume Sold Short$63,571.48Short Interest Ratio0.0 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares1,007,000 sharesShort Percent of Float1.63%Today's Trading Volume195,257 sharesAverage Trading Volume171,459 sharesToday's Volume Vs. Average114% Short Selling Kazia Therapeutics? Sign up to receive the latest short interest report for Kazia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKZIA Short Interest Over TimeKZIA Days to Cover Over TimeKZIA Percentage of Float Shorted Over Time Kazia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202581,200 shares $63,571.48 -29.9%1.6%0 $0.78 3/15/2025115,900 shares $115,343.68 +94.5%2.3%0.1 $1.00 2/28/202559,600 shares $50,743.44 -34.1%2.1%0 $0.85 2/15/202590,500 shares $80,545.00 -90.2%3.1%0.1 $0.89 1/31/2025921,900 shares $1.46 million +7,712.7%31.7%0.5 $1.58 1/15/202511,800 shares $18,290.00 +110.7%0.4%0.1 $1.55 12/31/20245,600 shares $9,912.00 -66.7%N/A0 $1.77 12/15/202416,800 shares $59,640.00 -24.7%N/A0.1 $3.55 11/30/202422,300 shares $115,291.00 -36.3%N/A0.2 $5.17 11/15/202435,000 shares $159,950.00 +86.2%N/A0.2 $4.57 Get the Latest News and Ratings for KZIA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202418,800 shares $101,520.00 -88.5%N/A0.1 $5.40 10/15/2024164,000 shares $54,136.40 -47.4%N/A0.1 $0.33 9/30/2024311,600 shares $133,956.84 -80.5%N/A0 $0.43 9/15/20241,600,000 shares $548,960.00 +388.1%N/A0.1 $0.34 8/31/2024327,800 shares $138,757.74 -21.8%N/A0 $0.42 8/15/2024418,900 shares $161,276.50 +85.0%N/A0 $0.39 7/31/2024226,400 shares $84,447.20 -93.3%N/A0 $0.37 7/15/20243,380,000 shares $1.89 million +7,076.2%N/A0.3 $0.56 6/30/202447,100 shares $10,767.06 +97.9%N/A0 $0.23 6/15/202423,800 shares $5,475.55 -10.2%N/A0.1 $0.23 5/31/202426,500 shares $6,890.00 -45.0%N/A0.1 $0.26 5/15/202448,200 shares $13,009.18 -44.0%N/A0.1 $0.27 4/30/202486,000 shares $28,792.80 +367.4%N/A0.1 $0.33 4/15/202418,400 shares $5,648.80 -92.9%N/A0 $0.31 3/31/2024259,500 shares $80,393.10 +6.9%N/A0.3 $0.31 3/15/2024242,800 shares $54,362.92 -68.3%N/A0.3 $0.22 2/29/2024765,100 shares $195,177.01 +1,566.9%N/A1.1 $0.26 2/15/202445,900 shares $14,242.77 -74.7%N/A0.1 $0.31 1/31/2024181,700 shares $54,328.30 +54.5%N/A1 $0.30 1/15/2024117,600 shares $41,148.24 +103.1%N/A1.1 $0.35 12/31/202357,900 shares $25,447.05 +32.8%N/A0.6 $0.44 12/15/202343,600 shares $17,047.60 -40.3%N/A0.5 $0.39 11/30/202373,000 shares $40,931.10 -35.6%N/A0.9 $0.56 11/15/2023113,400 shares $87,658.20 +1,889.5%N/A1.6 $0.77 10/31/20235,700 shares $2,393.43 -95.0%N/A0.1 $0.42 10/15/2023113,800 shares $77,384.00 +116.8%N/A3.1 $0.68 9/30/202352,500 shares $52,250.63 +10.3%N/A1.3 $1.00 9/15/202347,600 shares $48,076.00 -24.3%N/A0.3 $1.01 8/31/202362,900 shares $57,245.29 +10.5%N/A0.3 $0.91 8/15/202356,900 shares $51,329.49 -33.5%N/A0.3 $0.90Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. But something even more spectacular is bound to happen. And those who know what to expect could make 7/31/202385,600 shares $86,456.00 -2.5%N/A0.5 $1.01 7/15/202387,800 shares $76,745.98 -36.8%N/A0.5 $0.87 6/30/2023139,000 shares $158,460.00 -3.6%N/A0.8 $1.14 6/15/2023144,200 shares $181,692.00 -10.7%N/A4.7 $1.26 5/31/2023161,500 shares $192,185.00 +20.3%N/A4.8 $1.19 5/15/2023134,300 shares $178,619.00 -24.4%N/A3 $1.33 4/30/2023177,700 shares $236,341.00 +28.2%N/A3.9 $1.33 4/15/2023138,600 shares $182,952.00 -2.0%N/A2.8 $1.32 3/31/2023141,400 shares $145,656.14 +10.0%N/A2.7 $1.03 3/15/2023128,600 shares $120,768.26 -8.5%N/A2.2 $0.94 2/28/2023140,600 shares $129,352.00 -3.8%N/A2.3 $0.92 2/15/2023146,100 shares $131,490.00 -17.3%N/A2.6 $0.90 1/31/2023176,700 shares $182,001.00 -28.5%N/A2.8 $1.03 1/15/2023247,100 shares $259,455.00 +64.2%N/A0.7 $1.05 12/30/2022150,500 shares $92,542.45 -7.8%N/A0.4 $0.61 12/15/2022163,300 shares $89,145.47 -6.1%N/A0.5 $0.55 11/30/2022173,900 shares $104,966.04 -3.4%N/A0.5 $0.60 11/15/2022180,100 shares $118,866.00 -75.8%N/A0.5 $0.66 10/31/2022744,000 shares $614,767.20 +526.3%N/A2.1 $0.83 10/15/2022118,800 shares $118,800.00 +7.1%N/A0.4 $1.00 9/30/2022110,900 shares $121,990.00 -5.9%N/A0.4 $1.10 9/15/2022117,900 shares $168,597.00 -20.7%N/A0.3 $1.43 8/31/2022148,700 shares $227,511.00 -24.8%N/A0.2 $1.53 8/15/2022197,700 shares $345,975.00 +68.7%N/A0.3 $1.75 7/31/2022117,200 shares $425,436.00 -19.0%N/A0.2 $3.63 7/15/2022144,600 shares $539,358.00 +113.9%N/A0.4 $3.73 6/30/202267,600 shares $283,920.00 +90.4%N/A0.2 $4.20 6/15/202235,500 shares $191,700.00 +86.8%N/A0.1 $5.40 5/31/202219,000 shares $110,010.00 -21.2%N/A0.7 $5.79 5/15/202224,100 shares $132,309.00 +225.7%N/A1.2 $5.49 4/30/20227,400 shares $47,582.00 -53.5%N/A0.5 $6.43 4/15/202215,900 shares $121,317.00 +45.9%N/A1.2 $7.63 3/31/202210,900 shares $84,039.00 +445.0%N/A0.7 $7.71 3/15/20222,000 shares $12,100.00 -79.4%N/A0.1 $6.05 2/28/20229,700 shares $65,184.00 +592.9%N/A0.5 $6.72 2/15/20221,400 shares $10,514.00 +55.6%N/A0.1 $7.51 1/31/2022900 shares $6,030.00 -64.0%N/A0 $6.70 1/15/20222,500 shares $19,500.00 -19.4%N/A0.1 $7.80 12/31/20213,100 shares $26,102.00 -59.2%N/A0.1 $8.42 12/15/20217,600 shares $55,860.00 +20.6%N/A0.3 $7.35 11/30/20216,300 shares $63,189.00 +162.5%N/A0.2 $10.03 11/15/20212,400 shares $26,856.00 +4.4%N/A0.1 $11.19 10/29/20212,300 shares $24,909.00 -37.8%N/A0.1 $10.83 10/15/20213,700 shares $38,850.00 -67.8%N/A0.1 $10.50 9/30/202111,500 shares $130,180.00 -27.7%N/A0.5 $11.32 9/15/202115,900 shares $165,042.00 -29.0%N/A0.6 $10.38 8/31/202122,400 shares $243,040.00 +21.7%N/A0.7 $10.85 8/13/202118,400 shares $174,800.00 -18.6%N/A0.6 $9.50 7/30/202122,600 shares $204,078.00 -3.0%N/A0.6 $9.03 7/15/202123,300 shares $223,214.00 -16.5%N/A0.6 $9.58Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. But something even more spectacular is bound to happen. And those who know what to expect could make 6/30/202127,900 shares $275,094.00 +57.6%N/A0.5 $9.86 6/15/202117,700 shares $189,921.00 -18.1%N/A0.2 $10.73 5/28/202121,600 shares $205,416.00 -14.3%N/A0.2 $9.51 5/14/202125,200 shares $239,904.00 -38.2%N/A0.2 $9.52 4/30/202140,800 shares $444,720.00 +1,175.0%N/A0.3 $10.90 4/15/20213,200 shares $36,544.00 -88.5%N/A0 $11.42 3/31/202127,700 shares $333,508.00 -27.1%N/A0.2 $12.04 3/15/202138,000 shares $417,240.00 +32.9%N/A0.3 $10.98 2/26/202128,600 shares $297,154.00 +236.5%N/A0.2 $10.39 2/12/20218,500 shares $85,850.00 -18.3%N/A0 $10.10 1/29/202110,400 shares $99,424.00 -35.0%N/A0 $9.56 1/15/202116,000 shares $164,640.00 No ChangeN/A0 $10.29 KZIA Short Interest - Frequently Asked Questions What is Kazia Therapeutics' current short interest? Short interest is the volume of Kazia Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 81,200 shares of KZIA short. 1.63% of Kazia Therapeutics' shares are currently sold short. Learn More on Kazia Therapeutics' current short interest. Which institutional investors are shorting Kazia Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kazia Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Kazia Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.63% of Kazia Therapeutics' floating shares are currently sold short. Is Kazia Therapeutics' short interest increasing or decreasing? Kazia Therapeutics saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 81,200 shares, a decrease of 29.9% from the previous total of 115,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kazia Therapeutics' short interest compare to its competitors? 1.63% of Kazia Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kazia Therapeutics: Lakeshore Biopharma Co., Ltd. (0.40%), Cingulate Inc. (3.87%), MIRA Pharmaceuticals, Inc. (4.61%), GeoVax Labs, Inc. (9.16%), NeuroSense Therapeutics Ltd. (1.76%), GlycoMimetics, Inc. (4.18%), ImmunoPrecise Antibodies Ltd. (7.35%), Leap Therapeutics, Inc. (12.45%), Cellectar Biosciences, Inc. (4.90%), Cocrystal Pharma, Inc. (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Kazia Therapeutics stock? Short selling KZIA is an investing strategy that aims to generate trading profit from Kazia Therapeutics as its price is falling. KZIA shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kazia Therapeutics? A short squeeze for Kazia Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further. How often is Kazia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies LSB Short Squeeze CING Short Squeeze MIRA Short Squeeze GOVX Short Squeeze NRSN Short Squeeze GLYC Short Squeeze IPA Short Squeeze LPTX Short Squeeze CLRB Short Squeeze COCP Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZIA) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
